Advances in the genesis and risk stratification of myeloproliferative neoplasms: reports from the 56th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2015.03.006
- VernacularTitle:骨髓增殖性肿瘤发病机制及风险分层研究进展:第56届美国血液学会年会报道
- Author:
Luyang ZHANG
;
Ling PAN
- Publication Type:Journal Article
- Keywords:
Myeloproliferative neoplasm;
Pathogenesis;
Symptom assessment;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2015;24(3):147-151
- CountryChina
- Language:Chinese
-
Abstract:
Great advances have been made in understanding the genesis,diagnosis,risk stratification and the targeted therapy of myeloproliferative neoplasms (MPNs) in the past decade.This article reviews the current situation in the genesis,diagnosis and risk stratification of these classic bcr-abl-negative MPNs presented in the 56th American Society of Hematology (ASH) annual meeting.
